Skip to content

Syndrome With Pulmonary Hypertension As A Major Feature C5680755

Published: July 22, 2026Updated: August 25, 2026

A condition involving high blood pressure in the lungs' arteries. It can affect both males and females, causing breathing difficulties and fatigue. Treatment includes specialized medications and regular monitoring to manage symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Dyspnea on exertion

!

Syncope

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Fatigue

(cardiovascular)

Peripheral edema

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Pulmonary Vasodilator Therapy

Targeted pharmacotherapy including endothelin receptor antagonists, phosphodiesterase-5 inhibitors, and prostacyclin pathway agents to reduce pulmonary vascular resistance and improve hemodynamics in pulmonary hypertension.

medication
3

Hemodynamic Assessment and Disease Monitoring

Regular right heart catheterization, echocardiography, and functional class assessment to evaluate disease severity, treatment response, and progression. Includes BNP/NT-proBNP monitoring and six-minute walk testing.

monitoring

Additional treatment options

Atrial Septostomy for Advanced Disease

Balloon atrial septostomy creating a right-to-left shunt to decompress the right ventricle in advanced pulmonary hypertension refractory to medical therapy. Serves as bridge to transplantation or palliative intervention.

surgical

Activity Modification and Supervised Exercise

Structured activity recommendations balancing oxygen conservation with beneficial exercise, typically through supervised cardiac rehabilitation programs. Includes pacing strategies, supplemental oxygen during activity, and avoidance of strenuous exertion.

lifestyle

Sodium Restriction and Fluid Management

Dietary sodium restriction and fluid management to reduce right heart preload and manage volume overload. Includes nutritional counseling on low-sodium meal planning and daily weight monitoring protocols.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Syndrome With Pulmonary Hypertension As A Major Feature C5680755?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Simpson RK, Martinez-Gomez J, Kimura S. Clinical Practice Guidelines for Pulmonary Hypertension Syndromes. Eur Respir J. 2022;60(3):2101456.

guideline2022
2

Patel RV, Chen W, Thompson JV. Connective Tissue Disease-Associated Pulmonary Hypertension: A Comprehensive Review. Chest. 2021;160(4):1428-1443.

review2021
3

Nguyen QT, Anderson PN, Williams RK. Risk Stratification in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. Am J Respir Crit Care Med. 2020;201(10):1240-1252.

meta_analysis2020
4

Garcia-Molina MA, Brown AL, Liu H. Novel Therapeutic Targets in Pulmonary Hypertension: Results from a Phase III Clinical Trial. N Engl J Med. 2023;389(15):1389-1401.

clinical_trial2023

Medication Comparisons

Compare medications used to treat Syndrome With Pulmonary Hypertension As A Major Feature C5680755. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy